Mennecier Anaïs, Matoka Beauty, Wilfred-Tonga Maria Melany, Chunda-Liyoka Catherine, Mwiya Mwiya, Nagot Nicolas, Molès Jean-Pierre, Van de Perre Philippe, Kankasa Chipepo, King Rachel
Pathogenesis and Control of Chronic and Emerging Infections, Univ Montpellier, INSERM, EFS, Univ Antilles, Montpellier, France.
Pediatric Centre of Excellence, University Teaching Hospital, Lusaka, Zambia.
BMC Public Health. 2024 Dec 2;24(1):3356. doi: 10.1186/s12889-024-20855-5.
PROMISE-EPI trial evaluated a combination of interventions to prevent HIV transmission during breastfeeding. It showed a reduced postnatal transmission compared to the standard of care. The intervention combined identification of infants at high risk of infection using a point of care assay (POC) for early infant diagnosis and monitoring maternal viral load (VL) at 6 weeks and 6 months. A single-drug post-natal prophylaxis (PNP) was immediately initiated for high risk infants (maternal VL ≥ 1000 cp/mL). In Zambia, the national guidelines standard of care differs by 1) using three-drug PNP; 2) quarterly monitoring of maternal VL; 3) maternal VL testing in central labs. We explored the facilitators and barriers of this innovative prevention package to guide future scale-up.
Qualitative methods were used to gather information on PROMISE-EPI trial delivery, context, and behaviors. PROMISE-EPI intervention and control participants, staff members and health care professionals were interviewed. Verbatim transcripts were coded using a priori and emerging codes. Analysis was conducted using the RE-AIM (Reach, Effectiveness, Adoption, Implementation, Maintenance) framework. The determinants were categorized into the 5 domains of the Consolidated Framework for Implementation Research (CFIR) to better identify the causes of intervention success or failure among the 5 RE-AIM components.
A total of 37 individual interviews and 15 focus group discussions were conducted. Facilitators included the importance of the connection between the key elements of the intervention (POC and PNP) for immediate clinical action. Rapid maternal VL results induce several positive downstream behaviors in mothers and healthcare professionals, including increased trust in health care system. These can be quickly reversed when point of care testing is sub-optimal, as during the COVID-19 pandemic. Furthermore, the secondary elements of the intervention beyond POC and PNP; namely a warm welcome, a dedicated space, detailed and dedicated counselling, reimbursement for transport, solar panels and batteries, reminders and additional staff; were identified as facilitating its acceptability and fidelity.
This study provides new elements to better understand the reduced HIV transmission with the PROMISE-EPI intervention. It also highlights potential gaps between the package proposed in the trial and what can be applied in less controlled, 'real life' settings.
“PROMISE-EPI试验”评估了一系列干预措施,以预防母乳喂养期间的艾滋病毒传播。与标准护理相比,该试验显示产后传播有所减少。该干预措施结合了使用即时检测法(POC)识别感染高危婴儿以进行早期婴儿诊断,并在6周和6个月时监测母亲的病毒载量(VL)。对于高危婴儿(母亲病毒载量≥1000拷贝/毫升),立即启动单药产后预防(PNP)。在赞比亚,国家护理指南标准存在以下不同之处:1)使用三联药物产后预防;2)每季度监测母亲的病毒载量;3)在中心实验室进行母亲病毒载量检测。我们探讨了这一创新预防方案的促进因素和障碍,以指导未来的推广。
采用定性方法收集有关“PROMISE-EPI试验”实施、背景和行为的信息。对“PROMISE-EPI”干预组和对照组的参与者、工作人员和医疗保健专业人员进行了访谈。逐字记录使用先验编码和新出现的编码进行编码。使用RE-AIM(覆盖范围、有效性、采用率、实施、维持)框架进行分析。这些决定因素被归类到实施研究综合框架(CFIR)的5个领域,以便更好地确定干预措施在RE-AIM的5个组成部分中成功或失败的原因。
共进行了37次个人访谈和15次焦点小组讨论。促进因素包括干预措施的关键要素(即时检测法和产后预防)之间的联系对于立即采取临床行动的重要性。母亲病毒载量的快速检测结果在母亲和医疗保健专业人员中引发了一些积极的下游行为,包括对医疗保健系统的信任增加。当即时检测不理想时,如在COVID-19大流行期间,这些行为可能会迅速逆转。此外,即时检测法和产后预防之外的干预措施的次要要素,即热情欢迎、专用空间、详细且专门的咨询、交通费用报销、太阳能板和电池、提醒和额外工作人员,被确定为有助于提高其可接受性和保真度。
本研究提供了新的要素,以更好地理解“PROMISE-EPI”干预措施降低艾滋病毒传播的情况。它还突出了试验中提出的方案与在控制较少的“现实生活”环境中可应用的方案之间的潜在差距。